NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDRituximab Rixathon®Truxima® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
 Rituximab  Nutrition and blood, Drugs used in autoimmune thrombocytopenic purpura, 09.01.04
REDRituximab Truxima® Nutrition and blood, Drugs used in hypoplastic, haemolytic, and renal anaemias and in sickle cell disease, 09.01.03
REDRituximab Truxima® Musculoskeletal and joint diseases, Cytokine modulators, 10.01.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Rituximab  Rituximab Immune System, Immune System Disorders And Transplantation, Antineoplastic Drugs Monoclonal Antibodies
Rituximab  Rituximab Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Rituximab  Rituximab Musculoskeletal System, Arthritis, Antineoplastic Drugs Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Clinical Commissioning Policy; Rituximab and eculizumab for the prevention and management of delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies [URN 1821] [200602P]
NICE TA 649 Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma
NICE TA110: Follicular lymphoma - rituximab Non-Hodgkin's lymphoma - rituximab
NICE TA137: Lymphoma (follicular non-Hodgkin's) - rituximab
NICE TA174: Leukaemia (chronic lymphocytic, first line) - rituximab
NICE TA193: Leukaemia (chronic lymphocytic, relapsed) - rituximab
NICE TA226: Lymphoma (follicular non-Hodgkin’s) - rituximab
NICE TA243: Follicular lymphoma - rituximab (review)
NICE TA308: Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis
NICE TA472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab
NICE TA561: Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
NICE TA627: Lenalidomide with rituximab for previously treated follicular lymphoma
NICE TA629: Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab
NICE TA649: Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma
NICE TA65: Non-Hodgkin’s lymphoma - rituximab